Moreover, the relative expression of ABL1 mRNA was much higher in non-responders than responders (Fig. 1H), while the relative expression of BCR/ABL1 was similar among different CML patient groups (Fig. 1I). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.